Limbix

company

About

Limbix is a prescription digital therapeutics platform that provides mental health treatment for young people.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$15M
Industries
Biotechnology,Health Care,Medical,Medical Device,Therapeutics
Founded date
Oct 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

Limbix is a prescription digital therapeutic company passionate about creating mental health treatments for adolescents. The Limbix team is uniquely suited to develop prescription digital therapeutics, as its diverse team of clinicians, product designers, researchers, and engineers understand the value of pairing clinical expertise with technological innovation. Their first digital therapeutic, SparkRx by Limbix, is available for licensed healthcare professionals to offer to patients nationwide. For more information about Limbix and SparkRx, please visit limbix.com and SparkRx.com.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$27M
Limbix has raised a total of $27M in funding over 2 rounds. Their latest funding was raised on Dec 7, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 7, 2021 Series A $15M 1 Detail
May 5, 2020 Series A $9M 1 Detail
Nov 1, 2016 Seed $3M 1 Sequoia Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Limbix is funded by 2 investors. Gaingels and Sequoia Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Gaingels Series A
Sequoia Capital Series A